[Therapy of senile macular degeneration. Results of a multicenter study].
D000368:Aged; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005654:Fundus Oculi; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D012737:Sex Factors; D013805:Theobromine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014801:Vitamin A / Q000008:administration & dosage / Q000627:therapeutic use*; D014810:Vitamin E / Q000008:administration & dosage / Q000627:therapeutic use*
D004338:Drug Combinations; D009539:Nicotinic Acids; D014801:Vitamin A; D014810:Vitamin E; C025790:vitamin A, pentifyllin, nicotinic acid, and vitamin E combination; D013805:Theobromine
Therapie der senilen Makuladegeneration. Ergebnisse einer multizentrischen Studie.